These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 2908284
1. Beta-blockers, lipoproteins and non-insulin dependent diabetes. Feher MD, Rains SG, Richmond W, Torrens D, Wilson G, Wadsworth J, Sever PS, Elkeles RS. Postgrad Med J; 1988 Dec; 64(758):926-30. PubMed ID: 2908284 [Abstract] [Full Text] [Related]
2. Antihypertensive drugs and the hypertensive diabetic patient. Feher M. J Hum Hypertens; 1990 Oct; 4 Suppl 3():7-9. PubMed ID: 1979821 [Abstract] [Full Text] [Related]
3. Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes. Feher MD, Torrens DJ, Richmond W, Wadsworth J, Sever PS, Elkeles RS. J Hum Hypertens; 1988 Dec; 2(4):253-5. PubMed ID: 3236327 [Abstract] [Full Text] [Related]
4. Serum lipoproteins during treatment with antihypertensive drugs. Weidmann P, de Courten M, Ferrari P, Böhlen L. J Cardiovasc Pharmacol; 1993 Dec; 22 Suppl 6():S98-105. PubMed ID: 7508069 [Abstract] [Full Text] [Related]
5. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients. Bell DS, Bakris GL, McGill JB. Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334 [Abstract] [Full Text] [Related]
6. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects. Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS. J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930 [Abstract] [Full Text] [Related]
15. The effects of diuretics and adrenergic-blocking agents on plasma lipids. Rohlfing JJ, Brunzell JD. West J Med; 1986 Aug; 145(2):210-8. PubMed ID: 2876554 [Abstract] [Full Text] [Related]
16. PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION AMONG TYPE 2 DIABETIC PATIENTS AT MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA. Ndege BW, Diero LO, Owiti MO, Anjichi G, Siika AM. East Afr Med J; 2014 Aug; 91(8):253-60. PubMed ID: 26862649 [Abstract] [Full Text] [Related]
17. Do beta-blockers alter lipids and what are the consequences? Holtzman E, Rosenthal T, Goldbourt U, Segal P. J Cardiovasc Pharmacol; 1987 Aug; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177 [Abstract] [Full Text] [Related]
18. HDL cholesterol and beta-adrenoceptor blocking agents in a 5 year multifactorial primary prevention trial. Miettinen TA, Vanhanen H, Huttunen JK, Naukkarinen V, Mattila S, Strandberg T, Kumlin T. Br J Clin Pharmacol; 1982 Aug; 13(Suppl 2):431S-434S. PubMed ID: 6125196 [Abstract] [Full Text] [Related]
19. The association between antihypertensive drug therapies and plasma lipid levels in the general population. Maitland-van der Zee AH, Klungel OH, Kloosterman JM, Seidell JC, Leufkens HG, de Boer A. J Hum Hypertens; 2001 Oct; 15(10):701-5. PubMed ID: 11607800 [Abstract] [Full Text] [Related]
20. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients. Yamamoto T, Kitazawa Y, Noma A, Maeda S, Kato A, Ando Y, Ido T, Inazumi K, Hayakawa T, Goto Y, Ichien M. J Glaucoma; 1996 Aug; 5(4):252-7. PubMed ID: 8795770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]